Lisa Burnitt
Adult Health · Saint Louis, MONPI 1619249893
Payments from drug & device makers
Across 25 payments — averaging $25.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$138
- AbbVie$120
- GSK$98
- Amgen$53
- Novartis$44
- Lilly USA, LLC$41
- plus $149 from 7 others
What the payments were for
- Food & beverage$51580%
- Education$13020%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 3 | $138 |
| AbbVie | 5 | $120 |
| GSK | 1 | $98 |
| Amgen | 3 | $53 |
| Novartis | 2 | $44 |
| Lilly USA, LLC | 2 | $41 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Bayer | 2 | $27 |
| Dexcom, Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| UCB, Inc. | 1 | $18 |
| Exact Sciences | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
How this compares
$644 in reported general payments places this provider in the 55th percentile of 555 adult health providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 66 | $671,996 |
| Enbrel SureclickEtanercept | 42 | $337,503 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 11 | $81,943 |
| Hydroxychloroquine Sulfate | 250 | $8,184 |
| MethotrexateMethotrexate Sodium | 330 | $6,549 |
| Leflunomide | 114 | $5,529 |
| Cevimeline Hcl | 13 | $3,313 |
| Mycophenolate Mofetil | 19 | $3,120 |
| Celecoxib | 169 | $2,956 |
| Gabapentin | 119 | $2,239 |
| Prednisone | 339 | $1,909 |
| Pilocarpine Hcl | 16 | $1,658 |
| Duloxetine Hcl | 61 | $1,429 |
| Allopurinol | 158 | $1,296 |
| Colchicine | 24 | $1,275 |
Paid to pharmacies, not to this prescriber.
Other adult health in Saint Louis
- Stephanie VogelSaint Louis$115K
- Shannon TuckerSaint Louis$93K
- Laurencia KlipfelSaint Louis$79K
- Maria WallsSaint Louis$69K
- Jennifer SpeiserSaint Louis$27K
- Michele NobsSaint Louis$15K
- Lisa Koester WiedemannSaint Louis$14K
- Erin DoserSaint Louis$13K
- Marcee StegemeierSaint Louis$12K
- Heather PophamSaint Louis$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.